There is an increasing awareness that health care must move from post-symptomatic treatment to presymptomatic intervention. An ideal system would allow regular inexpensive monitoring of health status using circulating antibodies to report on health fluctuations. Recently, we demonstrated that peptide microarrays can do this through antibody signatures (immunosignatures). Unfortunately, printed microarrays are not scalable. Here we demonstrate a platform based on fabricating microarrays (~10 M peptides per slide, 330,000 peptides per assay) on silicon wafers using equipment common to semiconductor manufacturing. The potential of these microarrays for comprehensive health monitoring is verified through the simultaneous detection and classification of six different infectious diseases and six different cancers. Besides diagnostics, these high-density peptide chips have numerous other applications both in health care and elsewhere.
Details
- Scalable High-Density Peptide Arrays for Comprehensive Health Monitoring
- Legutki, Joseph Barten (Author)
- Zhao, Zhan-Gong (Author)
- Greving, Matt (Author)
- Woodbury, Neal (Author)
- Johnston, Stephen (Author)
- Stafford, Phillip (Author)
- Biodesign Institute (Contributor)
- Digital object identifier: 10.1038/ncomms5785
- Identifier TypeInternational standard serial numberIdentifier Value2041-1723
- The final version of this article, as published in Nature Communications, can be viewed online at: http://www.nature.com/articles/ncomms5785
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Legutki, J. B., Zhao, Z., Greving, M., Woodbury, N., Johnston, S. A., & Stafford, P. (2014). Scalable high-density peptide arrays for comprehensive health monitoring. Nature Communications, 5, 4785. doi:10.1038/ncomms5785